Stay updated on TERN-201 Safety and Efficacy in NASH Clinical Trial
Sign up to get notified when there's something new on the TERN-201 Safety and Efficacy in NASH Clinical Trial page.

Latest updates to the TERN-201 Safety and Efficacy in NASH Clinical Trial page
- Check3 days agoChange DetectedAdded related topics entries for Non-alcoholic fatty liver disease, including MedlinePlus Genetics. This improves access to NAFLD-related resources.SummaryDifference0.2%

- Check10 days agoChange DetectedThe page now displays Revision: v3.5.0. Related topics such as Non-alcoholic fatty liver disease and MedlinePlus Genetics, and the older Revision: v3.4.3, have been removed.SummaryDifference0.2%

- Check17 days agoChange DetectedThe page revision label changed from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check24 days agoChange DetectedAdded related topic entries: 'Non-alcoholic fatty liver disease' and 'MedlinePlus Genetics'. These appear in the page's related topics/MeSH terms section.SummaryDifference0.2%

- Check47 days agoChange DetectedThe page shows a new revision label 'Revision: v3.4.2' and the previous government funding status notice (and earlier 'Revision: v3.4.1') banner has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check54 days agoChange DetectedAdded a site-wide funding notice indicating NIH operations and updated the page to Revision: v3.4.1. Removed the Non-alcoholic fatty liver disease keyword and the MedlinePlus Genetics related topic from the page's metadata, and noted the prior revision tag v3.4.0.SummaryDifference0.6%

Stay in the know with updates to TERN-201 Safety and Efficacy in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TERN-201 Safety and Efficacy in NASH Clinical Trial page.